ATAGI has expanded the recommendations on winter COVID-19 booster doses for people at increased risk of severe COVID-19. See statement 

Fourth dose of COVID-19 vaccine Pfizer are available now for :

• Adults aged 65 years and over 
• Residents 16 years and older of aged care or disability care facilities
• Aboriginal and Torres Strait Islander adults aged 50 years and older

Additional groups recommended (from 25 May 2022)

People aged 16-64 years who have complex, chronic or severe conditions that are considered to increase their risk of severe illness from COVID-19 such as: 

• Cancer
• Chronic inflammatory conditions requiring medical treatment with disease modifying antirheumatic drugs (DMARDs) or immunesuppressive or immunomodulatory therapies.
• Chronic lung disease
• Chronic liver disease
• Severe chronic kidney disease (stage 4 or 5)
• Chronic neurological disease
• Diabetes mellitus requiring medication
• Chronic cardiac disease
• Severe obesity with BMI ≥ 40 kg/m2
• Severe underweight with BMI < 16.5 kg/m2

The following groups are currently not yet recommended to receive an additional winter booster dose:
• Healthy people aged 16 to 64 years of age who do not have any risk factors for severe COVID-19
• Women who are pregnant without any other comorbidity that increases their risk of severe COVID-19
• People from occupational groups, such as healthcare workers, who do not have any other comorbidity that increases their risk of severe COVID-19.

If you do meet the criteria for a winter dose of COVID-19 vaccine: 

• These appointments can be booked online via our website under the 'Booster dose' appointment type. 
• The interval is 4 months after your 3rd dose. Please ensure you only book if you are eligible.